New studentship on digital tools and dermatology

Green Templeton is delighted to announce the availability of funded studentship for a DPhil project in Translational Health Sciences thanks to support from Oxford PharmaGenesis.

The project will address ‘Disrupting dermatology: can digital tools overcome the challenges of algorithmic bias and threats to professionalism in dermatology to deliver benefits to patients and services?’ and the call for applications is now open and will close on Friday 29 July 2022 at 12:00.

The successful candidate will have their tuition fees covered (Home or Overseas level) and will receive an annual stipend of at least £16,077. They will also be eligible for an additional allowance to help with the cost of childcare during their studies.

The project itself will explore perspectives and concerns about racial bias in the development, uptake and implementation of digital health technologies/artificial intelligence for skin disease. As a related but secondary objective in addressing ethnic health disparities, it will also examine the professional issues in the adoption of these disruptive technologies.

It is anticipated that the proposed DPhil will draw on sociological perspectives and that the project design and methods will be qualitative or mixed methods (e.g. using interviews, focus groups, ethnography and evidence synthesis). Patient and Public Involvement and Engagement will be embedded throughout, from design to dissemination. Experts in digital health and in dermatology will also be engaged. Communication will be key to the outputs of the DPhil, including to raise awareness of findings amongst clinicians and other users of AI of the need to take account of diversity, including through using diverse training sets. See full details about the project and details of how to apply

This studentship forms part of a larger and ongoing partnership with Oxford PharmaGenesis, an independent, award-winning HealthScience communications consultancy. Oxford PharmaGenesis has also this year supported the Green Templeton Lectures on science and the media and the Human Welfare Conference on arts and human welfare.

Sir Michael Dixon, Principal, Green Templeton College said,

‘This is an important new area of research and I’m delighted that we can extend the college’s partnership with Oxford PharmaGenesis to pioneer fresh thinking. I’m grateful for the ongoing support of CEO Chris Winchester, who is also an Associate Fellow and member of the Principal’s Circle, and look forward to further developing our partnership.

‘I’m particularly pleased that this studentship will offer the possibility of a childcare allowance for the successful candidate as an extension of Green Templeton’s family-friendly and enabling environment for all.’

Chris Winchester, CEO, Oxford PharmaGenesis said,

‘Patients are at the heart of everything we do; we are therefore thrilled to support this studentship, which will help to better understand and address racial and ethnic inequalities in the field of digital healthcare. Advancing diversity and inclusivity is of great importance to our clients, our company and our employees. We are excited to create the opportunity for the successful candidate to draw on best research practices to help optimise the equitable use of digital tools in dermatological practice, for the benefit of all.’

The student will become a member of Green Templeton College and the project will be based at Nuffield Department of Primary Care Health Sciences. They will be supervised by Senior Research Fellow Professor Catherine Pope, Professor John Powell and Dr Abi McNiven.

Created: 1 July 2022